Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skylight 1: Fezolinetant for Menopausal Hot Flashes
NCT04003155Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of fezolinetant in vasomotor symptoms, sponsored by Astellas Pharma. Started Jul 2019; status: completed.
02
Drugs
fezolinetant
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT04003155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04003155.